Trial intelligence / Profile preview

Impact of intense exercise on pharmacokinetics of glucocorticoids in relation to doping analysis

2014-005186-73Phase 4Completed

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Jan 2015
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of methylprednisolone, methylprednisolone sodium succinate and hydrocortisone butyrate, sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Urine concentration of glucocorticoids. Started Jan 2015; status: completed.

02

Drugs

methylprednisolonemethylprednisolone sodium succinatehydrocortisone butyrate

Beyond the preview

Go deeper on 2014-005186-73.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005186-73.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call